Open hour: senin - sabtu 09:00:00 - 20:00:00; minggu & tanggal merah tutup
References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [4]

References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [4]

author: Eijiro Sakamoto, Rie Kido, Yoritoki Tomotake, Yoshihito Naitou, Yuichi Ishida, Jun-ichi Kido | publisher: drg. Andreas Tjandra, Sp. Perio, FISID

Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants. 1998;13:689–96.

Melo RF, Lopes BM, Shibli JA, Marcantonio E Jr, Marcantonio RA, Galli GM. Interleukin-1β and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res. 2012;14:905–14.

Kivelä-Rajamäki MJ, Teronen OP, Maisi P, Husa V, Tervahartiala TI, Pirilä EM, et al. Laminin-5γ2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid. Clin Oral Implants Res. 2003;14:158–65.

Renvert S, Lindahl C, Roos Jansåker AM, Persson GR. Treatment of peri-implantitis using an Er:YAG laser or an air-abrasive device: a randomized clinical trial. J Clin Periodontol. 2011;38:65–73.

Schwarz F, Sahm N, Iglhaut G, Becker J. Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical study. J Clin Periodontol. 2011;38:276–84.

Sanz M, Chapple IL, on behalf of Working Group 4 of the VIII European Workshop on Periodontology. Clinical research on peri-implant diseases: consensus report of working group 4. J Clin Periodontol. 2012;39(Suppl. 12):202–6.

Giannobile WV. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci. 1999;878:404–12.

Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139–46.

Rakic M, Lekovic V, Nikolic-Jakoba N, Vojvodic D, Petkovic-Curcin A, Sanz M. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. Clin Oral Implants Res. 2013;24:1110–6.

Sarlati F, Sattari M, Gazar AG, Rafsenjani AN. Receptor activator of nuclear factor kappa B ligand (RANKL) levels in peri-implant crevicular fluid. Iran J Immunol. 2010;7:226–33.

Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res. 1988;226:267–91.

Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1β in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res. 2002;13:637–43.

Serial posts:


id post:
New thoughts
Me:
search
glossary
en in